Acomplia and Tobacco

Studies conducted on rimonabant have shown that people on the pill could not just lose weight but keep it off for two years — a feat no other diet pill has achieved so far. Like a double-action pill, Rimonabant can combat the world's two leading causes of death: smoking and obesity. Rimonabant has also been called anti-marijuana because it blocks hungry signals experienced by smokers of the herb.

Unfortunately, it is not that simple for all the obese people around the world to smoothen their weight loss training and even by abiding a weight loss tips, they are unable to avert the risk of life threatening obesity related diseases. Especially in cases of morbid obesity, where the Body Mass Index (BMI) is beyond 40, the doctor usually recommends drug therapy in conjunction to the lifestyle changes to prevent the risk of life-threatening obesity related diseases.

Rimonabant works by selectively blocking some of the receptors in the endocannabinoid system, balancing the overstimulated systems of both smokers and obese people. By blocking the signals, the overeater or nicotine addict does not have the same urge to eat or smoke. The endocannabinoid system is a natural physiological system believed to play a role in maintaining energy balance through the regul

The studies and trials conducted on the weight loss drug have shown that people who’ve used this drug were able to quit and stay off cigarettes significantly and also did not put on weight that generally happens when a person quits smoking.

Obesity is a growing problem and rimonabant can play a big role in combating the disease. Therefore, once the drug gets approval, it’s going to rule the diet pill market for years to come.